Genome sharing
US-2024406179-A1 · Dec 5, 2024 · US
US9792403B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9792403-B2 |
| Application number | US-201414274525-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2014 |
| Priority date | May 10, 2013 |
| Publication date | Oct 17, 2017 |
| Grant date | Oct 17, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems for analyzing genetic variants are disclosed.
Opening claim text (preview).
What is claimed is: 1. A method of characterizing a variant in a tumor sample from a subject as being a somatic or germline event, the method comprising: a) sequencing each of a plurality of selected subgenomic intervals, each of a plurality of selected germline SNPs, and a variant, wherein the average sequence coverage prior to normalization is at least about 250×; b) acquiring: i) a sequence coverage input (SCI), which comprises, for each of the plurality of selected subgenomic intervals, a value for normalized sequence coverage at the selected subgenomic intervals, wherein SCI comprises a comparison of the number of reads for a subgenomic interval with the number of reads for a process-matched control; ii) an SNP allele frequency input (SAFI), which comprises, for each of the plurality of selected germline SNPs, a value for a minor allele frequency in the tumor sample; and iii) for said variant being characterized, a variant allele frequency input (VAFI), which comprises the allele frequency for said variant in the tumor sample; c) acquiring values, as a function of SCI and SAFI, for: a genomic segment total copy number (C) for each of a plurality of genomic segments; a genomic segment minor allele copy number (M) for each of the plurality of genomic segments; and sample purity (p), wherein SCI, SAFI, C, M, and p are related to one another by the following: r ij ∼ N ( log 2 p * C i + ( 1 - p ) * 2 p * ( ∑ i l i c i ) / ∑ i l i + ( 1 - p ) * 2 , σ ri , and fik ∼ N ( p * Mi + ( 1 - p ) * 1 p * Ci + ( 1 - p ) * 2 , σ fi ) , when SCI and SAFI are notated as r ij and f ik , respectively; and where r ij is the log ratio (LR) of subgenomic interval j within a genomic segment (S i ), C i is the total copy number (C) of S i , l i is the length of S i , fik is the minor allele frequency of SNP k within S i , M i is the copy number of a minor allele (M) at S i , and σ ri and σ fi are noise parameters; and d) acquiring a value for mutation type, g, for which is indicative of the variant, being somatic, a subclonal somatic variant, germline, or not-distinguishable, wherein g, VAFI, p, C, and M are related to one another by the following: VAFI = pM + g ( 1
ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations · CPC title
Physics · mapped topic
Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection · CPC title
Ploidy or copy number detection · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.